← Leaderboards
Steven J Fishman
Children'S Hospital Boston
$76,627
Attributed
$76,627
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $42.1K · FY2005–06$50K$37.5K$25K$12.5K$0
'05
'06
Funding mix
By agency
NIH$76,627 · 2
By mechanism
M01$76,627 · 2
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Elizabeth C. Engle$19,215,363
- Judah Folkman$11,710,747
- Marsha A Moses$6,062,315
- Donald E Ingber$21,971,527
- Mustafa None Sahin$24,290,295
Others in their field
Top investigators on “Cardiovascular Disorder Chemotherapy”
- James F Toole · Wake Forest University Health Sciences$17,951,480
- Christopher M O'Connor · Duke University$16,943,599
- Leslie L Robison · University Of Minnesota Twin Cities$16,102,450
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$14,553,633
- Dan M Roden · Vanderbilt University Medical Center$11,317,563
- Andrew G. Bostom · Rhode Island Hospital (Providence, Ri)$10,300,000
Research focus
Cardiovascular Disorder ChemotherapyClinical ResearchClinical Trial Phase ICollagenaseCongenital Cardiovascular DisorderDisabling DiseaseDosageDrug Screening /EvaluationEnzyme InhibitorsExtracellular Matrix ProteinsHuman SubjectHuman Therapy EvaluationMetalloendopeptidasesNeoplastic ProcessPatient Oriented ResearchProtein DegradationStromelysin
Grant awards (3)
SAFETY/EFFICACY OF MARIMASTAT IN PATIENTS WITH DISABLING VASCULAR MALFORMATIONS$14,770
M01 · FY2006 · RR · contact PI
SAFETY/EFFICACY OF MARIMASTAT IN PATIENTS WITH DISABLING VASCULAR MALFORMATIONS$42,122
M01 · FY2005 · RR
Safety/efficacy of Marimastat in Patients with Disabling Vascular Malformations$19,735
M01 · FY2004 · RR